Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 90 member A6, pseudogene (FAM90A6P) is classified as a pseudogene, meaning it is a genomic DNA sequence resembling a protein-coding gene but is generally considered nonfunctional due to mutations, deletions, or lack of regulatory elements required for protein expression. The sequence shows homology to the Family with sequence similarity 90 genes, but there is no evidence it encodes a functional protein or acts as a receptor, enzyme, or other druggable target. While some pseudogenes have regulatory RNA-based functions in certain biological or disease contexts, there is no indication in current gene databases or literature that FAM90A6P possesses such roles. FAM90A6P is consistently described as a pseudogene in major gene annotation databases and references. Pseudogenes generally do not produce functional proteins and are not considered therapeutic targets. Their roles, if any, are usually limited to RNA-based regulation, and where described, those are often gene-specific and not universal to all pseudogenes. No drugs, safety profiles, or use as biomarkers are documented for this pseudogene. The term "pseudogene" explicitly indicates that this locus is not a protein-coding, functional, or druggable gene, and does not represent a standard biological target such as a receptor or enzyme. FAM90A6P is not considered a therapeutic or molecular target by current standards.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 90 member A6, pseudogene (FAM90A6P).